Side-by-side financials for ATOS and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATOS | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #48 |
| Revenue (latest FY) | $1.76K | - |
| Net income (latest FY) | -$34.77M | - |
| Net margin | -1977815.7% | - |
| SEC filings | 634 | 1,004 |
Full pages: ATOSSA THERAPEUTICS, INC. and AstraZeneca PLC, or browse the full rankings.